Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents

References

• FordTGoodmanRMeltzerHThe British child and adolescent mental health survey 1999: the prevalence of DSM-IV disordersJ Am Acad Child Adolesc Psychiatry200342101203121114560170
   PubMed Web of Science ®Google Scholar
• SayalKFordTGoodmanRTrends in recognition of and service use for attention-deficit hyperactivity disorder in Britain, 1999–2004Psychiatr Serv201061880381020675839
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association, American Psychiatric AssociationDSM-5 Task ForceDiagnostic and Statistical Manual of Mental Disorders: DSM-55thWashington, DCAmerican Psychiatric Association2013
   Google Scholar
• Vande VoortJLHeJPJamesonNDMerikangasKRImpact of the DSM-5 attention-deficit/hyperactivity disorder age-of-onset criterion in the US adolescent populationJ Am Acad Child Adolesc Psychiatry201453773674424954823
   PubMed Web of Science ®Google Scholar
• WillcuttEGThe prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic reviewNeurotherapeutics20129349049922976615
   PubMed Web of Science ®Google Scholar
• BloomBJonesLIFreemanGSummary health statistics for U.S. children: National Health Interview Survey, 2012Vital Health Stat201310258181
   Google Scholar
• PolanczykGde LimaMSHortaBLBiedermanJRohdeLAThe worldwide prevalence of ADHD: a systematic review and metaregression analysisAm J Psychiatry2007164694294817541055
   PubMed Web of Science ®Google Scholar
• PolanczykGVSalumGASugayaLSCayeARohdeLAAnnual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescentsJ Child Psychol Psychiatry201556334536525649325
   PubMed Web of Science ®Google Scholar
• PolanczykGRohdeLAEpidemiology of attention-deficit/hyperactivity disorder across the lifespanCurr Opin Psychiatry200720438639217551354
   PubMed Web of Science ®Google Scholar
• FroehlichTELanphearBPEpsteinJNBarbaresiWJKatusicSKKahnRSPrevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US childrenArch Pediatr Adolesc Med2007161985786417768285
   PubMed Web of Science ®Google Scholar
• FrankeBNealeBMFaraoneSVGenome-wide association studies in ADHDHum Genet20091261135019384554
   PubMed Web of Science ®Google Scholar
• FaraoneSVPerlisRHDoyleAEMolecular genetics of attention-deficit/hyperactivity disorderBiol Psychiatry200557111313132315950004
   PubMed Web of Science ®Google Scholar
• SprichSBiedermanJCrawfordMHMundyEFaraoneSVAdoptive and biological families of children and adolescents with ADHDJ Am Acad Child Adolesc Psychiatry200039111432143711068899
   PubMed Web of Science ®Google Scholar
• HawiZCumminsTDTongJThe molecular genetic architecture of attention deficit hyperactivity disorderMol Psychiatry201520328929725600112
   PubMed Web of Science ®Google Scholar
• Salatino-OliveiraAGenroJPPolanczykGCadherin-13 gene is associated with hyperactive/impulsive symptoms in attention/deficit hyperactivity disorderAm J Med Genet B Neuropsychiatr Genet2015168B316216925739828
   PubMed Web of Science ®Google Scholar
• LeschKPMerkerSReifANovakMDances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHDEur Neuropsychopharmacol201223647949122939004
   PubMed Web of Science ®Google Scholar
• SagvoldenTJohansenEBAaseHRussellVAA dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypesBehav Brain Sci2005283397419 [discussion 419–368]16209748
   PubMed Web of Science ®Google Scholar
• HasueRHShammah-LagnadoSJOrigin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the ratJ Comp Neurol20024541153312410615
   PubMed Web of Science ®Google Scholar
• OadesRDHallidayGMVentral tegmental (A10) system: neurobiology. 1. Anatomy and connectivityBrain Res198743421171653107759
   PubMed Web of Science ®Google Scholar
• SchultzWGetting formal with dopamine and rewardNeuron200236224126312383780
   PubMed Web of Science ®Google Scholar
• JohansenEBKilleenPRRussellVAOrigins of altered reinforcement effects in ADHDBehav Brain Funct20095719226460
   PubMed Web of Science ®Google Scholar
• SagvoldenTAaseHZeinerPBergerDAltered reinforcement mechanisms in attention-deficit/hyperactivity disorderBehav Brain Res199894161719708840
   PubMed Web of Science ®Google Scholar
• PaloyelisYAshersonPKuntsiJAre ADHD symptoms associated with delay aversion or choice impulsivity? A general population studyJ Am Acad Child Adolesc Psychiatry200948883784619564796
   PubMed Web of Science ®Google Scholar
• PaloyelisYMehtaMAFaraoneSVAshersonPKuntsiJStriatal sensitivity during reward processing in attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry2012517722e732e72922721595
   PubMed Web of Science ®Google Scholar
• PlichtaMMVasicNWolfRCNeural hyporesponsiveness and hyperresponsiveness during immediate and delayed reward processing in adult attention-deficit/hyperactivity disorderBiol Psychiatry200965171418718573
   PubMed Web of Science ®Google Scholar
• FooteSLBloomFEAston-JonesGNucleus locus ceruleus: new evidence of anatomical and physiological specificityPhysiol Rev19836338449146308694
   PubMed Web of Science ®Google Scholar
• Aston-JonesGRajkowskiJCohenJLocus coeruleus and regulation of behavioral flexibility and attentionProg Brain Res200012616518211105646
   PubMed Web of Science ®Google Scholar
• Cohen-YavinIYoran-HegeshRStrousRDKotlerMWeizmanASpivakBEfficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trialClin Neurophar-macol2009324179182
   Web of Science ®Google Scholar
• StahlSMThe prefrontal cortex is out of tune in attention-deficit/hyperactivity disorderJ Clin Psychiatry200970795095119653972
   PubMed Web of Science ®Google Scholar
• SaraSJLearning by neurones: role of attention, reinforcement and behaviourC R Acad Sci19983212–31931989759340
   PubMed Web of Science ®Google Scholar
• BerridgeCWWaterhouseBDThe locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processesBrain Res Brain Res Rev2003421338412668290
   PubMedGoogle Scholar
• DevilbissDMBerridgeCWLow-dose methylphenidate actions on tonic and phasic locus coeruleus dischargeJ Pharmacol Exp Ther200631931327133516980569
   PubMed Web of Science ®Google Scholar
• CarboniESilvagniADopamine reuptake by norepinephrine neurons: exception or rule?Crit Rev Neurobiol2004161–212112815581407
   PubMedGoogle Scholar
• MinerLHSchroeterSBlakelyRDSesackSRUltrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminalsJ Comp Neurol2003466447849414566944
   PubMed Web of Science ®Google Scholar
• VanicekTSpiesMRami-MarkCThe norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomographyJAMA Psychiatry201471121340134925338091
   PubMed Web of Science ®Google Scholar
• DingYSSinghalTPlaneta-WilsonBPET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRTSynapse2010641303819728366
   PubMed Web of Science ®Google Scholar
• SimmlerLDRickliASchrammYHoenerMCLiechtiMEPharmacological profiles of aminoindanes, piperazines, and pipradrol derivativesBiochem Pharmacol201488223724424486525
   PubMed Web of Science ®Google Scholar
• HannestadJGallezotJDPlaneta-WilsonBClinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivoBiol Psychiatry201068985486020691429
   PubMed Web of Science ®Google Scholar
• van de GiessenEBooijJThe SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young menEur J Nucl Med Mol Imaging20103781507151120309682
   PubMed Web of Science ®Google Scholar
• PunjaSZorzelaLHartlingLUrichukLVohraSLong-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacyBMJ Open201333
   Web of Science ®Google Scholar
• KhajehpiriZMahmoudi-GharaeiJFaghihiTKarimzadehIKhaliliHMohammadiMAdverse reactions of methylphenidate in children with attention deficit-hyperactivity disorder: report from a referral centerJ Res Pharm Pract20143413013625535621
   PubMedGoogle Scholar
• MillerGMThe emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activityJ Neurochem2011116216417621073468
   PubMed Web of Science ®Google Scholar
• ViggianoDRuoccoLAArcieriSSadileAGInvolvement of nor-epinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorderNeural Plast2004111–213314915303310
   PubMedGoogle Scholar
• GoodmanDWLisdexamfetamine dimesylate: the first prodrug stimulantPsychiatry (Edgmont)200748394520532026
   PubMedGoogle Scholar
• FaraoneSVBiedermanJRoeCComparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysisJ Clin Psychopharmacol200222546847312352269
   PubMed Web of Science ®Google Scholar
• ManosMJShortEJFindlingRLDifferential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry199938781381910405498
   PubMed Web of Science ®Google Scholar
• FaraoneSVUpadhyayaHPThe effect of stimulant treatment for ADHD on later substance abuse and the potential for medication misuse, abuse, and diversionJ Clin Psychiatry20076811e2818052554
   PubMedGoogle Scholar
• StahlSMNeurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortexJ Clin Psychiatry200364323023112716261
   PubMed Web of Science ®Google Scholar
• HanwellaRSenanayakeMde SilvaVComparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysisBMC Psychiatry20111117622074258
   PubMed Web of Science ®Google Scholar
• StuhecMMundaBSvabVLocatelliIComparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropionJ Affect Disord201517814915925813457
   PubMed Web of Science ®Google Scholar
• AwuduGABesagFMCardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an updateDrug Saf201437966167625124483
   PubMed Web of Science ®Google Scholar
• BangsMETauscher-WisniewskiSPolzerJMeta-analysis of suicide-related behavior events in patients treated with atomoxetineJ Am Acad Child Adolesc Psychiatry200847220921818176331
   PubMed Web of Science ®Google Scholar
• de JongeATimmermansPBvan ZwietenPAQuantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. I. Central hypotensive and peripheral hypertensive activitiesJ Pharmacol Exp Ther198222237057116125586
   PubMed Web of Science ®Google Scholar
• SalleeFRThe role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorderPostgrad Med20101225788720861591
   PubMed Web of Science ®Google Scholar
• JainRSegalSKollinsSHKhayrallahMClonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry201150217117921241954
   PubMed Web of Science ®Google Scholar
• KollinsSHJainRBramsMClonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHDPediatrics20111276e1406e141321555501
   PubMed Web of Science ®Google Scholar
• Shionogi Pharma IKAPVAY (clonidine hydrochloride) extended-release tablets, oral [Package Insert]2010
   Google Scholar
• UhlenSWikbergJEDelineation of rat kidney alpha 2A- and alpha 2B-adrenoceptors with [3H]RX821002 radioligand binding: computer modelling reveals that guanfacine is an alpha 2A-selective compoundEur J Pharmacol199120222352431666366
   PubMed Web of Science ®Google Scholar
• SastreMGarcia-SevillaJAAlpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtypeJ Neurochem1994633107710857914222
   PubMed Web of Science ®Google Scholar
• WangMRamosBPPaspalasCDAlpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortexCell2007129239741017448997
   PubMed Web of Science ®Google Scholar
• SwartzBEKovalikEThomasKTorgersenDMandelkernMAThe effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsyNeuropsychopharmacology200023326327510942850
   PubMed Web of Science ®Google Scholar
• AveryRAFranowiczJSStudholmeCvan DyckCHArnstenAFThe alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory taskNeuropsychopharmacology200023324024910942848
   PubMed Web of Science ®Google Scholar
• ClerkinSMSchulzKPHalperinJMGuanfacine potentiates the activation of prefrontal cortex evoked by warning signalsBiol Psychiatry200966430731219520360
   PubMed Web of Science ®Google Scholar
• GyiresKZadoriZSTorokTMatyusPalpha(2)-Adrenoceptor subtypes-mediated physiological, pharmacological actionsNeurochem Int200955744745319477210
   PubMed Web of Science ®Google Scholar
• FranowiczJSArnstenAFActions of alpha-2 noradrenergic agonists on spatial working memory and blood pressure in rhesus monkeys appear to be mediated by the same receptor subtypePsychopharmacology (Berl)2002162330431212122489
   PubMed Web of Science ®Google Scholar
• BoremanCDArnoldLEHallucinations associated with initiation of guanfacineJ Am Acad Child Adolesc Psychiatry20034212138714627872
   PubMed Web of Science ®Google Scholar
• ShireINTUNIV (guanfacine) extended-release tablets [Package Insert]2009
   Google Scholar
• BiedermanJMelmedRDPatelASPD503 Study GroupA randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorderPediatrics20081211e73e8418166547
   PubMed Web of Science ®Google Scholar
• ConnorDFFindlingRLKollinsSHEffects of guanfacine extended release on oppositional symptoms in children aged 6–12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trialCNS Drugs201024975576820806988
   PubMed Web of Science ®Google Scholar
• KollinsSHLópezFAVinceBDPsychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol201121211112021476931
   PubMed Web of Science ®Google Scholar
• NewcornJHSteinMAChildressACRandomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administrationJ Am Acad Child Adolesc Psychiatry201352992193023972694
   PubMed Web of Science ®Google Scholar
• SalleeFRMcGoughJWigalTDonahueJLyneABiedermanJGuanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trialJ Am Acad Child Adolesc Psychiatry200948215516519106767
   PubMed Web of Science ®Google Scholar
• ScahillLChappellPBKimYSA placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorderAm J Psychiatry200115871067107411431228
   PubMed Web of Science ®Google Scholar
• RizzoRMartinoDGuanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescentsExpert Rev Neurother201515434735425800130
   PubMed Web of Science ®Google Scholar
• RuggieroSClavennaARealeLCapuanoARossiFBonatiMGuan-facine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysisEur Neuropsychopharmacol201424101578159025156577
   PubMed Web of Science ®Google Scholar
• SalleeFRKollinsSHWigalTLEfficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol201222320621422612526
   PubMed Web of Science ®Google Scholar
• HervasAHussMJohnsonMEfficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trialEur Neuropsychopharmacol201424121861187225453486
   PubMed Web of Science ®Google Scholar
• HirotaTSchwartzSCorrellCUAlpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapyJ Am Acad Child Adolesc Psychiatry201453215317324472251
   PubMed Web of Science ®Google Scholar
• ZetterqvistJAshersonPHalldnerLLangstromNLarssonHStimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009Acta Psychiatr Scand20131281707722943458
   PubMed Web of Science ®Google Scholar
• YoungJRuginoTDammermanRLyneANewcornJHEfficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified conners’ parent rating scale-revised: short formJ Child Adolesc Psychopharmacol201424843544125286026
   PubMed Web of Science ®Google Scholar
• FDAIntuniv (Guanfacine Extended-Release); Pediatric Post-Marketing Adverse Event ReviewSilver SpringCenter for Drug Evaluation and Research2011
   Google Scholar